Invention Grant
- Patent Title: Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione
-
Application No.: US15999447Application Date: 2017-02-15
-
Publication No.: US11111218B2Publication Date: 2021-09-07
- Inventor: Thomas Martin , Josef Breu , Juliane Fleissner , Wolfgang Brysch , Jörg Von Wegerer
- Applicant: METRIOPHARM AG
- Applicant Address: CH Zürich
- Assignee: METRIOPHARM AG
- Current Assignee: METRIOPHARM AG
- Current Assignee Address: CH Zürich
- Agency: Haug Partners LLP
- Priority: EP16000379 20160216
- International Application: PCT/EP2017/000227 WO 20170215
- International Announcement: WO2017/140430 WO 20170824
- Main IPC: A61K31/502
- IPC: A61K31/502 ; C07D237/32 ; A61K9/00 ; A61K45/06
Abstract:
A new crystalline form of 5-amino-2,3-dihydro-1,4-phthalazinedione (luminol) is provided. Advantageous uses for this crystalline form as a detecting agent or as an agent for forensic purposes are disclosed, as well a pharmaceutical composition containing said crystalline form.
Public/Granted literature
- US20200369624A1 CRYSTALLINE FORM OF 5-AMINO-2, 3-DIHYDROPHTHALAZINE-1, 4-DIONE Public/Granted day:2020-11-26
Information query
IPC分类:
